← Eichor
Study identifier: NCT07040566 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Trial of Varenicline for E-cigarette Cessation

Condition: E-cigarette Use · Vaping · Nicotine Dependence  ·  Sponsor: Yale University

PhasePhase 2
Planned participants326
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is randomized, placebo-controlled clinical trial in treatment-seeking adults who report regular e-cigarette use to test the hypothesis that varenicline is efficacious for quitting e-cigarettes.

This description comes directly from the study's public registry record.

Talk to the study team

Lisa Fucito, PhD  ·  2032001470  ·  lisa.fucito@yale.edu

Michael Fatigate, PhD  ·  Michael.fatigate@yale.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Yale Cancer Center/Smilow Cancer Hospital at Yale-New HavenNew Haven, Connecticut, United StatesRecruiting
Hollings Cancer Center at MUSC (HCC)Charleston, South Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07040566